Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph not_applicable
3
75%
Ph early_phase_1
1
25%

Phase Distribution

1

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Early Phase 1First-in-human
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Early Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Other(4)

Detailed Status

unknown4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
N/A
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (25.0%)
N/A3 (75.0%)

Trials by Status

unknown4100%

Recent Activity

0 active trials
Showing 4 of 4
unknownnot_applicable

Efficacy and Analgesic Use During the Therapy of Iatrogenic Pneumothorax Using Pleuralvent™ and Chest Tube

NCT03700554
unknownnot_applicable

Two-Lumen Catheterization For Lung Wedge Resection

NCT03230019
unknownearly_phase_1

Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis

NCT02825095
unknownnot_applicable

Tubeless VATS for Peripheral Lung Nodule

NCT02817048

Clinical Trials (4)

Showing 4 of 4 trials
NCT03700554Not Applicable

Efficacy and Analgesic Use During the Therapy of Iatrogenic Pneumothorax Using Pleuralvent™ and Chest Tube

Unknown
NCT03230019Not Applicable

Two-Lumen Catheterization For Lung Wedge Resection

Unknown
NCT02825095Early Phase 1

Management of Malignant Pleural Effusion - Indwelling Pleural Catheter or Talc Pleurodesis

Unknown
NCT02817048Not Applicable

Tubeless VATS for Peripheral Lung Nodule

Unknown

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4